Imatge de la portada

Clear Cell Renal Cell Carcinoma 2022–2023

Clear cell renal cell carcinoma is a common tumor in Western countries and an appropriate test subject for new therapies. This Special Issue highlights the most up-to-date research into clear cell renal cell carcinoma from different medical perspectives, including its diagnosis, prognosis, and treat...

Descripció completa

Guardat en:
Format: Online
Idioma:anglès
Publicat: MDPI - Multidisciplinary Digital Publishing Institute 2024
Matèries:
TIME (tumor immune microenvironment)
synchronous
metachronous
mRCC (metastatic renal cell carcinoma)
PD-L1
immunophenotype
imaging
renal cell carcinoma
biomarker
renal mass
radiomics
radiogenomics
circadian rhythm
clock genes
immunotherapy
HIF
immune microenvironment
tumor immunology
immune checkpoint inhibitor
cystic renal neoplasm
differential diagnosis
single-cell RNA-seq
cell-of-origin
tumor microenvironment
stromal cells
immune cells
novel therapies
predictive biomarkers
prognostic biomarkers
therapeutic monitoring
immune checkpoint inhibitors
VEGF inhibitors
metastatic disease
nitric oxide
signalling
ccRCC
cohort study
partial nephrectomy
radical nephrectomy
perioperative outcomes
mortality
tumor heterogeneity
T cell
mRCC
complement
classical pathway
“aggressive complement” tumor
biomarkers
cancer
cholesterol
LDL
HDL
VLDL
NPC1
TKI
indirect comparison
Shiny method
reconstructed individual patient data
disease-free survival
adjuvant setting
n/a
thema EDItEUR::P Mathematics and Science::PB Mathematics::PBW Applied mathematics
Accés en línia:ONIX_20240514_9783725804757_320
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
Sumari:Clear cell renal cell carcinoma is a common tumor in Western countries and an appropriate test subject for new therapies. This Special Issue highlights the most up-to-date research into clear cell renal cell carcinoma from different medical perspectives, including its diagnosis, prognosis, and treatment.

Ítems similars